Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson's disease is not…

The anti-dyskinetic and the anti-parkinsonian effects of sub-anesthetic ketamine are also present in female preclinical models
R. Parmar, M. J. Bartlett, J. R. Meredith +4
bioRxiv27 Oct 2026PreprintAll rights reservedFull textNeurosciencebioRxiv
AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex
Noelle Callizot, Georgia Culley, Grace Flower +7
PLOS One30 Sep 2026Peer-reviewedCC BY 4.0Full textCell biology NeurosciencePLOS
The Small Molecule DDOX Confers Neuroprotection and Alleviates Motor Deficits in a Preclinical Rat Model of Parkinson's Disease
Lorena Borges, Glauce Crivelaro Do Nascimento, Laurent Ferrié +4
Neurotoxicity Research2 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textNeuroscience Pharmacology & toxicologyHAL
The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021–2025 State‐of‐the‐Art Review of Clinical and Preclinical Evidence
Luigi Maria Chiatto, Lucia Buccarello, Giuseppe Carota +5
Pharmacology Research & Perspectives1 Jun 2026Peer-reviewedCC BY5 citedNeuroscienceOpenAlex
Brassinosteroids improve nitrogen utilization by antagonizing BIN2-mediated SnRK1 activation
Lianmei Yao, Jinyang Lyu, Yan Qiao +9
Nature Communications17 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textPlant biologyCrossref

Cite

BibTeX

@misc{stopera2026neuroprotective,
  title = {{Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson's disease is not blocked by antagonizing brain-derived neurotrophic factor signaling}},
  author = {Carolyn J. Stopera and Mitchell J. Bartlett and Kelsey Bernard and Rachel Conklin and Sansita Singh and Jennifer B. Frye and Lalitha Madhavan and Kristian R. Doyle and Scott J. Sherman and Kathy Steece-Collier and Torsten Falk},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.28.762430},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.28.762430v1},
}

RIS

TY  - UNPB
TI  - Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson's disease is not blocked by antagonizing brain-derived neurotrophic factor signaling
AU  - Carolyn J. Stopera
AU  - Mitchell J. Bartlett
AU  - Kelsey Bernard
AU  - Rachel Conklin
AU  - Sansita Singh
AU  - Jennifer B. Frye
AU  - Lalitha Madhavan
AU  - Kristian R. Doyle
AU  - Scott J. Sherman
AU  - Kathy Steece-Collier
AU  - Torsten Falk
PY  - 2026
DA  - 2026/10/28
PB  - bioRxiv
DO  - 10.64898/2026.10.28.762430
UR  - https://www.biorxiv.org/content/10.64898/2026.10.28.762430v1
SN  - 2692-8205
ER  -

Related

Cite